SCHEMBL12496277

SCHEMBL12496277

CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)OC[C@@H](COCc3ccccc3)NC4=O)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 4/20 0.38
▸ CDC7 O00311 2/20 0.36
▸ HTR2A P28223 3/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ FYN P06241 3/20 0.34
▸ MAP4K4 O95819 2/20 0.34
▸ MINK1 Q8N4C8 2/20 0.34
▸ TNIK Q9UKE5 2/20 0.34
▸ ALOX5AP P20292 2/20 0.33
▸ FEN1 P39748 2/20 0.33
▸ AXL P30530 1/20 0.33
▸ MERTK Q12866 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ PI4KB Q9UBF8 1/20 0.33
▸ HTR1A P08908 2/20 0.32
▸ DRD2 P14416 2/20 0.32
▸ HTR7 P34969 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12496280 1.00 KCNH2 (0.38) KCNH2CDC7HTR2AHTR2CMAPK1
SCHEMBL18936977 0.87 KCNH2 (0.43) KCNH2FYNMAP4K4MINK1TNIK
SCHEMBL18936976 0.87 KCNH2 (0.43) KCNH2FYNMAP4K4MINK1TNIK
SCHEMBL12496246 0.83 KCNH2 (0.43) KCNH2HTR2AHTR2CFYNMAP4K4
SCHEMBL12496244 0.83 KCNH2 (0.43) KCNH2HTR2AHTR2CFYNMAP4K4
SCHEMBL18936952 0.83 KCNH2 (0.43) KCNH2HTR2AHTR2CFYNMAP4K4
SCHEMBL12496293 0.77 KCNH2 (0.43) KCNH2MAPK1FYNMAP4K4MINK1
SCHEMBL12495782 0.72 KCNH2 (0.43) KCNH2HTR2AHTR2CFYNMAP4K4
SCHEMBL12495780 0.72 KCNH2 (0.43) KCNH2HTR2AHTR2CFYNMAP4K4
SCHEMBL18936979 0.71 KCNH2 (0.46) KCNH2HTR2AHTR2CMAPK1FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2681206-B1 MST1 KINASE INHIBITORS AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS INC (US) 2017-06-14 — — EP disclosed
EP-2681206-A1 MST1 KINASE INHIBITORS AND METHODS OF THEIR USE Lexicon Pharmaceuticals, Inc. (US) 2014-01-08 — — EP disclosed
WO-2012121992-A1 MST1 KINASE INHIBITORS AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS, INC. (US) 2012-09-13 — — WO disclosed
Send feedback